| 2009 | A case of wernicke's encephalopathy following fluorouracil-based chemotherapy | 이순남; 성주명; 이경은; 문영철; 남은미 | Article |
| 2012 | A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemia | 허정원; 문영철 | Article |
| 2022 | A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naive, high-risk essential thrombocythemia as a primary treatment | 문영철 | Article |
| 2019 | A Phase I/II, Open-Label, Prospective, Multicenter Study to Evaluate the Efficacy and Safety of Lower Doses of Bortezomib Plus Busulfan and Melphalan as a Conditioning Regimen in Patients with Multiple Myeloma Undergoing Autologous Peripheral Blood Stem Cell Transplantation: The KMM103 Study | 문영철 | Article |
| 2020 | A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis | 문영철 | Article |
| 2013 | A proposal for improvement in the utilization rate of banked cord blood | 문영철 | Note |
| 2005 | A prospective randomized study on the mobilization of CD34+ cells comparing continuous intravenous vs subcutaneous administration of rhG-CSF in normal donors | 이미애; 성주명; 유은선; 이경은; 문영철 | Article |
| 2023 | A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients with Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone | 문영철 | Article |
| 2015 | A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome | 문영철 | Article |
| 2017 | A prospective, open-label, multicenter, observational study to evaluate the efficacy and safety of bortezomib-melphalanprednisone as initial treatment for autologous stem cell transplantation-ineligible patients with multiple myeloma | 문영철 | Article |
| 2012 | ABL1 deletion without BCR/ABL1 rearrangement is originated from a large-sized 9q deletion | 정화순; 성주명; 허정원; 문영철 | Letter |
| 2016 | ACQUIRED HLA-B*40:02 MUTATION LEADING TO FRAME SHIFT IN DIOPATHIC APLASTIC ANEMIA | 허정원; 문영철 | Meeting Abstract |
| 2009 | Acute fibrinous and organizing pneumonia following hematopoietic stem cell transplantation | 이순남; 성순희; 성주명; 김유경; 이경은; 문영철 | Article |
| 2013 | Acute promyelocytic leukemia with a rare PML Exon 4/RARA exon 3 fusion transcript variant | 정화순; 성주명; 허정원; 문영철 | Article |
| 2012 | Additional genomic aberrations identified by single nucleotide polymorphism array-based karyotyping in an acute myeloid leukemia case with isolated del(20q) abnormality | 정화순; 성주명; 허정원; 문영철 | Article |
| 2012 | ADDITIONAL GENOMIC ABERRATIONS IDENTIFIED BY SNP-ARRAY BASED KARYOTYPING IN CASES WITH ISOLATED DEL(9Q) OR DEL(20Q) ABNORMALITY | 정화순; 성주명; 허정원; 문영철 | Meeting Abstract |
| 2003 | Adherent cells generated during long-term culture of human umbilical cord blood CD34+ cells have characteristics of endothelial cells and beneficial effect on cord blood ex vivo expansion | 이순남; 이미애; 서정완; 정화순; 성주명; 유은선; 허정원; 이경은; 문영철 | Article |
| 2011 | Adverse prognostic impact of abnormal lesions detected by genome-wide single nucleotide polymorphism array-based karyotyping analysis in acute myeloid leukemia with normal karyotype | 허정원; 문영철 | Article |
| 2008 | ANALYSIS OF CHARACTERISTICS IN CURATIVELY RESECTED STAGE IV GASTRIC CANCER PATIENTS | 문영철 | Meeting Abstract |
| 2015 | Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome | 문영철 | Article |
| 2011 | Bortezomib Induction Followed by ASCT in Patients with Multiple Myeloma: Achievement of Response After Induction and Achieving CR Post-ASCT Are Both Important Prognostic Markers | 문영철 | Meeting Abstract |
| 2017 | BORTEZOMIB-MELPHALAN-PREDNISONE VERSUS MP AS INITIAL TREATMENT FOR VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA | 문영철 | Meeting Abstract |
| 2015 | Calreticulin mRNA expression and clinicopathological characteristics in acute myeloid leukemia | 정화순; 성주명; 허정원; 문영철; 정혜선 | Article |
| 2007 | CD34, RAB20, DLK1, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome | 홍기숙; 정화순; 성주명; 허정원; 문영철 | Meeting Abstract |
| 2009 | CD34, RAB20, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome | 홍기숙; 이미애; 정화순; 성주명; 허정원; 문영철 | Article |
| 2016 | Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients | 문영철 | Article |
| 2014 | Changes in osteoblastic activity in patient who received bortezomib as second line treatment for plasma cell myeloma: A prospective multicenter study | 문영철 | Article |
| 2011 | Characteristics of myelodysplastic syndrome, unclassifiable by WHO classification 2008 | 정화순; 성주명; 허정원; 문영철 | Letter |
| 2008 | Characterization of phenotypically distinct B-cell subsets and receptor-stimulated mitogen-activated protein kinase activation in human cord blood B cells | 성주명; 이종란; 문영철 | Article |
| 2014 | Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: Web-based multicenter registry study | 문영철 | Article |
